Advancing outcomes in CP-CML: Guideline-directed approaches to treatment decision-making, monitoring and toxicity management
touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY
Listen to leading experts discuss guideline-directed strategies for mutational analysis and monitoring response when treating patients with chronic-phase chronic myeloid leukaemia with approved tyrosine kinase inhibitors.
The experts
Dr Jorge Cortes, Georgia Cancer Center, Augusta, GA, USA
Dr Elias Jabbour, MD Anderson Cancer Center, Houston, TX, USA
Dr Vivian Oehler, Fred Hutch Cancer Center, Seattle, WA, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Takeda…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.